12 Comments
 

heard Mercury is a scam - any other HH that is willing to talk to SS ER?

 
Most Helpful

A few things to your question - I know SS ER gets a lot of hate sometimes, but I'm relatively junior into my career covering a hot sector. Outside of money being great (benchmarking against some of the posts here, I think I'm getting more than usual with ~1YOE and TC ~200K) and my analyst being a good person, I don't think I know my sector well enough to generate that much value for the buy-side. I also like my work and the client interactions I've had as an associate so far. 

For the buy-side, I know it's all about performance in the end, but I think I'll be in a much stronger position if I give myself a few more years - still lots to learn/room for comp growth. Of course, I might be biased in this area because I've always worked for very good analysts; I'm currently on a ranked team, and started off at an independent that mimicked the buy-side. Sometimes I think people from SS jump to the buy-side too quickly without discerning fund quality/platform stability, which is fine, but it's easy to get blown out. Personally, I've seen a few associates lasting just a year before going back to SS + a slight downgrade. For now, I like the stability of my job and the brand name on my resume. Ideally, after a few years, I'd leave for LO or VC, but would be open if these opportunities present themselves earlier (I've gotten some traction with VCs early on). I'm also not opposed to staying in SS ER either and becoming an analyst, simply because of how much growth my sector has (in case someone asks, it's HC but not biotech). Hope this helps!

 

Impedit reprehenderit magni dolorem dolores. Rerum rem culpa assumenda necessitatibus aut dolor. Recusandae sint animi dicta et delectus.

Omnis laboriosam perspiciatis similique nam. Sed aliquam eligendi at ipsa consequatur soluta harum. Sit aut voluptas eligendi ut. Odio assumenda quidem dolores aliquid eos.

Quia eum aut explicabo ut tenetur asperiores assumenda explicabo. Eligendi non ipsa labore voluptas cumque at vitae. Illo voluptas eius voluptatem. Corporis labore eum repellat animi. Tenetur in explicabo non maxime maxime magni. Iure laborum veniam aut quo blanditiis qui.

Career Advancement Opportunities

September 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Goldman Sachs 01 97.8%
  • Morgan Stanley 07 97.3%

Overall Employee Satisfaction

September 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 98.9%
  • Evercore 01 98.4%
  • Banco Santander 02 97.8%
  • BMO Capital Markets 12 97.3%

Professional Growth Opportunities

September 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 07 98.4%
  • Goldman Sachs 01 97.8%
  • JPMorgan No 97.3%

Total Avg Compensation

September 2026 Investment Banking

  • Vice President (16) $429
  • Associates (51) $260
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (26) $182
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
dosk17's picture
dosk17
98.9
6
GameTheory's picture
GameTheory
98.9
7
DrApeman's picture
DrApeman
98.9
8
Betsy Massar's picture
Betsy Massar
98.9
9
CompBanker's picture
CompBanker
98.9
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”